The Role of CRISPR Technology in Advancing Personalized Medicine: Commercial and Ethical Considerations

Mehmet Kaya
Boğaziçi University, Turkey

DOI:https://doi.org/10.5912/jcb2524

Abstract:

Because of CRISPR technology, genes can be edited very precisely which allows for the treatment of hereditary diseases, different complex conditions, and even cancer. With these advancements, alongside ethical and regulatory challenges, such as the ease of genetic editing and access control make it even more perplexing. It has also drawn immense investment into biotechnology which led towards the realization of promise gene-editing therapies. Overall, there is great potential to CRISPR, but the ethical questions that arise alongside it are equally as troubling. Through this technology, genetic changes can be made that go far beyond what is accepted in modern medicine, which is responsible for the division between moral and commercial interests. Through this paper, we discuss the need for comprehensive policies that deal with marketing CRISPR technology in personalized medicine and other functional areas for the betterment of the society as a whole. CRISPR is shifting the paradigm for personalized medicine, potentially creating groundbreaking opportunities but also presenting significant ethical and commercial challenges. Implied consequences demand action in fostering innovation while ensuring access, ethical consideration, as well as strong regulatory oversight. The future of healthcare with CRISPR will greatly depend on ongoing scientific, judicious commercialization, and moral policy decision making.